Overview
- Coverage for puberty blockers, cross-sex hormones and gender-affirming surgeries is now excluded, while psychological assessment and psychotherapy related to gender dysphoria remain covered.
- The Fourth Circuit on Sept. 23 vacated the 2022 district court order requiring coverage and remanded the case, with the mandate reaching the trial court on Wednesday.
- The case returns to the Middle District of North Carolina without a judge currently assigned.
- Treasurer Brad Briner announced implementation and said about 500 members could be affected out of roughly 750,000 covered by the plan.
- Earlier wins for the plaintiffs at trial and on appeal were undone procedurally after the Supreme Court’s June order directing reconsideration in light of United States v. Skrmetti.